Charles Net Receivables vs Other Current Liab Analysis
CRL Stock | USD 196.63 2.44 1.26% |
Charles River financial indicator trend analysis is way more than just evaluating Charles River Labora prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Charles River Labora is a good investment. Please check the relationship between Charles River Net Receivables and its Other Current Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Charles River Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Net Receivables vs Other Current Liab
Net Receivables vs Other Current Liab Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Charles River Labora Net Receivables account and Other Current Liab. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Charles River's Net Receivables and Other Current Liab is 0.98. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Other Current Liab in the same time period over historical financial statements of Charles River Laboratories, assuming nothing else is changed. The correlation between historical values of Charles River's Net Receivables and Other Current Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of Charles River Laboratories are associated (or correlated) with its Other Current Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Current Liab has no effect on the direction of Net Receivables i.e., Charles River's Net Receivables and Other Current Liab go up and down completely randomly.
Correlation Coefficient | 0.98 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Net Receivables
Other Current Liab
Most indicators from Charles River's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Charles River Labora current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Charles River Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. At this time, Charles River's Selling General Administrative is quite stable compared to the past year. Discontinued Operations is expected to rise to about 1.8 M this year, although Enterprise Value Over EBITDA will most likely fall to 9.06.
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 73.9M | 59.3M | 136.7M | 143.5M | Depreciation And Amortization | 265.5M | 303.9M | 314.1M | 329.8M |
Charles River fundamental ratios Correlations
Click cells to compare fundamentals
Charles River Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Charles River fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 4.7B | 5.5B | 7.0B | 7.6B | 8.2B | 8.6B | |
Short Long Term Debt Total | 2.0B | 2.1B | 2.9B | 3.1B | 3.1B | 3.2B | |
Other Current Liab | 388.3M | 409.6M | 553.1M | 531.3M | 605.5M | 635.8M | |
Total Current Liabilities | 710.2M | 839.8M | 1.0B | 1.1B | 1.1B | 1.1B | |
Total Stockholder Equity | 1.6B | 2.1B | 2.5B | 3.0B | 3.6B | 3.8B | |
Property Plant And Equipment Net | 1.2B | 1.3B | 1.6B | 1.9B | 2.0B | 2.1B | |
Current Deferred Revenue | 171.8M | 207.9M | 219.7M | 264.3M | 241.8M | 253.9M | |
Net Debt | 1.8B | 1.9B | 2.7B | 2.9B | 2.8B | 2.9B | |
Retained Earnings | 280.3M | 625.4M | 980.8M | 1.4B | 1.9B | 2.0B | |
Accounts Payable | 111.5M | 122.5M | 198.1M | 205.9M | 168.9M | 177.4M | |
Cash | 238.0M | 228.4M | 241.2M | 233.9M | 276.8M | 172.3M | |
Non Current Assets Total | 3.7B | 4.3B | 5.8B | 6.2B | 6.6B | 6.9B | |
Non Currrent Assets Other | 89.6M | 130.8M | 151.5M | 148.3M | 309.4M | 324.9M | |
Cash And Short Term Investments | 238.0M | 228.4M | 241.2M | 233.9M | 276.8M | 173.9M | |
Net Receivables | 514.0M | 617.7M | 642.9M | 752.4M | 780.4M | 819.4M | |
Common Stock Total Equity | 489K | 498K | 505K | 509K | 585.4K | 681.5K | |
Common Stock Shares Outstanding | 49.7M | 50.6M | 51.4M | 51.3M | 51.5M | 55.4M | |
Liabilities And Stockholders Equity | 4.7B | 5.5B | 7.0B | 7.6B | 8.2B | 8.6B | |
Non Current Liabilities Total | 2.3B | 2.5B | 3.4B | 3.5B | 3.5B | 3.7B | |
Inventory | 160.7M | 185.7M | 199.1M | 255.8M | 380.3M | 399.3M | |
Other Current Assets | 56.0M | 165.2M | 190.9M | 196.9M | 171.3M | 179.8M | |
Other Stockholder Equity | 1.5B | 1.6B | 1.7B | 1.8B | 1.9B | 1.3B | |
Total Liab | 3.0B | 3.3B | 4.4B | 4.6B | 4.5B | 4.8B | |
Property Plant And Equipment Gross | 1.2B | 1.1B | 1.6B | 1.9B | 3.4B | 3.5B | |
Total Current Assets | 1.0B | 1.2B | 1.3B | 1.4B | 1.6B | 1.7B | |
Accumulated Other Comprehensive Income | (178.0M) | (138.9M) | (164.7M) | (262.1M) | (196.4M) | (186.6M) | |
Short Term Debt | 38.5M | 74.9M | 36.1M | 50.2M | 441.1M | 463.2M | |
Common Stock | 489K | 498K | 505K | 509K | 513K | 670.0K | |
Intangible Assets | 689.4M | 787.6M | 1.1B | 955.3M | 864.1M | 480.2M | |
Other Liab | 350.2M | 422.2M | 482.6M | 390.4M | 449.0M | 471.4M | |
Other Assets | 134.3M | 1.5B | (47.2M) | 1K | 1.2K | 1.1K | |
Long Term Debt | 1.8B | 1.9B | 2.6B | 2.7B | 2.6B | 2.8B | |
Good Will | 1.5B | 1.8B | 2.7B | 2.8B | 3.1B | 3.2B | |
Property Plant Equipment | 1.0B | 1.1B | 1.6B | 1.9B | 2.1B | 2.2B | |
Short Term Investments | 941K | 1.0M | 1.1M | 998K | 898.2K | 853.3K | |
Net Tangible Assets | (566.7M) | (456.7M) | (1.2B) | (786.5M) | (707.8M) | (672.4M) | |
Noncontrolling Interest In Consolidated Entity | 3.2M | 3.6M | 4.2M | 4.8M | 5.5M | 3.4M | |
Retained Earnings Total Equity | 280.3M | 625.4M | 980.8M | 1.4B | 1.6B | 1.7B |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in Charles River Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Charles River. If investors know Charles will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Charles River listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.21) | Earnings Share 8 | Revenue Per Share 78.97 | Quarterly Revenue Growth (0.02) | Return On Assets 0.0487 |
The market value of Charles River Labora is measured differently than its book value, which is the value of Charles that is recorded on the company's balance sheet. Investors also form their own opinion of Charles River's value that differs from its market value or its book value, called intrinsic value, which is Charles River's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Charles River's market value can be influenced by many factors that don't directly affect Charles River's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Charles River's value and its price as these two are different measures arrived at by different means. Investors typically determine if Charles River is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Charles River's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.